Table 2.

Characteristics of 578 Mild Cognitive Impairment (MCI) patients by anti-Alzheimer's Disease medication use group.

Characteristic	On Anti-AD* Medications	No Anti-AD* Medications	P Value
	Mean (± sd)* or N (%)
Age	77.5 (7.2)	74.2 (10.6)	< 0.001
Above HS* Education	125 (75.3%)	297 (72.1%)	0.201
Non-White Race	132 (79.5%)	315 (76.5%)	0.426
Male	93 (56.0%)	203 (49.3%)	0.132
MMSE*	26.1 (2.9)	26.8 (2.7)	0.006
Diabetes	27 (16.3%)	86 (20.9%)	0.206
Hypertension	110 (66.3%)	256 (62.1%)	0.351
Myocardial Infarct	14 (8.4%)	31 (7.5%)	0.712
Stroke/TIA*	24 (14.5%)	51 (12.4%)	0.501
BRDRS*	2.3 (2.2)	1.4 (2.1)	< 0.001
Site	---	---	< 0.001
Amnestic Disorder	59 (35.5%)	95 (23.1%)	0.002
Single Mild Non- Memory Cognitive Impairment	17 (10.2%)	47 (11.4%)	0.679
Mild Neurocognitive Disorder	58 (34.9%)	151 (36.7%)	0.684
MCI*- Petersen or ADCS Criteria	60 (36.1%)	180 (43.7%)	0.091

^*AD = Alzheimer's Disease; HS = high school; MMSE = Mini Mental Status Examination (range = 0 – 30 where lower score indicates poorer performance); TIA = transient ischemic attack; BRDRS = Blessed-Roth Dementia Rating Scale (range = 0 – 17 where higher score indicates poorer performance); sd = standard deviation